Evidence map›Paper›PMID 26829648›Full record

ArticlePloS one2016

Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils.

Bozena Dziadek, Anna Brzostek, Marcin Grzybowski, Marek Fol, Agnieszka Krupa, Jakub Kryczka, Przemyslaw Plocinski, Anna Kurdowska, Jaroslaw Dziadek

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The role ofFrontiers in cellular and infection microbiology · 2023
    Review
  6. Cells · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. A Two-Way Proteome Microarray Strategy to Identify NovelFrontiers in cellular and infection microbiology · 2019
    Article
  11. Systematic Identification ofMolecular & cellular proteomics : MCP · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Bozena DziadekDepartment of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Anna BrzostekInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Marcin GrzybowskiDepartment of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Marek FolDepartment of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Agnieszka KrupaInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Jakub KryczkaInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Przemyslaw PlocinskiLaboratory of RNA Biology and Functional Genomics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Anna KurdowskaDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, Texas, United States of America.
Jaroslaw DziadekInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Institute for Medical Biology · PLUniversity of Łódź · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLPolish Academy of Sciences · PLThe University of Texas Health Science Center at Tyler · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis is an extremely successful intracellular pathogen that has evolved a broad spectrum of pathogenic mechanisms that enable its manipulation of host defense elements and its survival in the hostile environment inside phagocytes. Cellular influx into the site of mycobacterial entry is mediated by a variety of chemokines, including interleukin-8 (IL-8), and the innate cytokine network is critical for the development of an adaptive immune response and infection control. Using affinity chromatography, liquid chromatography electrospray ionization tandem mass spectrometry and surface plasmon resonance techniques, we identified M. tuberculosis AtsG arylsulphatase, bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyl transferase (GlmU) and S-adenosyl-L-homocysteine hydrolase (SahH) as the pathogen proteins that bind to human IL-8. The interactions of all of the identified proteins (AtsG, GlmU and SahH) with IL-8 were characterized by high binding affinity with KD values of 6.83x10-6 M, 5.24x10-6 M and 7.14x10-10 M, respectively. Furthermore, the construction of Mtb mutant strains overproducing AtsG, GlmU or SahH allowed determination of the contribution of these proteins to mycobacterial entry into human neutrophils. The significantly increased number of intracellularly located bacilli of the overproducing M. tuberculosis mutant strains compared with those of "wild-type" M. tuberculosis and the binding interaction of AtsG, GlmU and SahH proteins with human IL-8 may indicate that these proteins participate in the modulation of the early events of infection with tubercle bacilli and could affect pathogen attachment to target cells.

Indexed as

AnimalsBacterial AdhesionBacterial ProteinsDisease Models, AnimalFemaleHumansImmune SeraInterleukin-8MiceMutationMycobacterium tuberculosisNeutrophilsProtein BindingRecombinant ProteinsTuberculosisBacterial ProteinsImmune SeraInterleukin-8Recombinant Proteins

Identifiers

PMID26829648
PMCPMC4734655
OpenAlexW2266947097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.